⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
Bispecific Antibody Drug Conjugates Market Landscape Report 2026: A $2 Billion Opportunity by 2030 with the 1st Approved BsADC by 2028 - Clinical Trials, Regulatory Approvals, Development Platforms
globenewswire.com
AMGN
AZN
GMAB
Bispecific Antibody Market Landscape Report 2026: A Potential $60 Opportunity by 2031 - Insight on More than 550 Clinical Trials - Antibody Dosage, Patent, Price, Sales & Outlook
globenewswire.com
JNJ
AMGN
GMAB
ABBV
AZN
PFE
BMY
REGN
XNCR
ZYME
Targeted Alpha Therapy Market Landscape Report 2026-2030: Clinical Trials Insights on 30 Drugs - Size, Regulatory Approvals, Proprietary Technologies, Therapeutic Applications
globenewswire.com
ACIU
AZN
BMY
Lung Cancer Therapeutics Market to Reach $49.5 Billion by 2030, Driven by Rising Cancer Incidence and R&D Investment Surge
globenewswire.com
AZN
MRK
BMY
PFE
AMGN
ISPE Announces 2026 Facility of the Year Awards (FOYA) Category Winners
prnewswire.com
AMGN
SNY
LLY
AZN
TAK
Arrayed CRISPR Screening Market Presents Lucrative Opportunities Through 2026-2030: Total Revenue to Grow by $1.64 Billion at 17.7% CAGR
globenewswire.com
TMO
MRK
GEHC
AZN
Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD
businesswire.com
AZN
Urology Devices Market to Reach $58.63 Billion by 2031 with Robotic Urologic Surgery Systems Projected to Expand at a 10.31% CAGR, Reports Mordor Intelligence
globenewswire.com
ALC
JNJ
BLCO
BSX
ABT
MDT
LIF
CAH
AZN
SNY
TMO
AIM ImmunoTech Enters Pivotal Value Inflection Phase with Planned Phase 3 Study of Ampligen® in Pancreatic Cancer, Backed by Positive Clinical Signals, Orphan Drug Status, and Global IP
globenewswire.com
AIM
AZN
SnapLogic Announces AI Gateway and Trusted Agent Identity to Power the Era of Digital Labor
globenewswire.com
AZN
ADBE
VZ
SONY